AI (Artificial Intelligence) in a GxP Environment + AI in Visual Inspections - Live Online Training
29-31 October 2024
Seminar-Nr. 21786
Referent:innen
Klaus Feuerhelm
Regierungspräsidium Tübingen
Haluk Dönmez
B. Braun
Felix Krumbein
Head ECA Visual Inspection Group
Stefan Münch
Körber Pharma Consulting
Yves Samson
Kereon
Martin Heitmann
d-fine
Daniel Wolf
Universitätsklinikum Ulm
Ib Alstrup
Danish Medicines Agency (DKMA)
Stefan Hessel
Reusch Rechtsanwaltsgesellschaft
Felix Georg Müller
plus10
Urs Alexander Peter
HC Dr. Herterich & Consultants
Hendrik Rolshausen
DHC Dr. Herterich & Consultants
Dr Juergen Schmitz
GSK Vaccines
Zielsetzung
(AI) Artificial Intelligence in a GxP Environment
Why should you participate in this event?
You will learn the basics of AI / ML and its applicability in the GxP Environment
How can pharmaceutical basics, e.g. risk management and qualification / validation be applied to AI? You will experience first approaches!
Are relevant pharmaceutical regulations adapted to this new technology and what expectations does an inspector have during an inspection? First concepts will be presented!
In case studies, pharmaceutical companies show first practical and practised approaches to the use of AI
(AI) Artificial Intelligence in Visual Inspection
The pharmaceutical industry is increasingly interested in AI for the visual inspection of parenterals to optimize and enhance process efficacy. However, the lack of specific regulatory requirements for AI validation poses challenges from a Good Manufacturing Practice (GMP) perspective, such as data representativeness, model design, and data integrity throughout the product lifecycle. In visual inspection, AI aims to improve efficiency by reducing the false acceptance rate (FAR) of defect units and the false reject rate (FRR) of good units, which together determine the misclassification rate and the inspection process‘s effectiveness. A high FAR is associated with a possible quality risk, while the FRR is a measure of the economic damage of the selected control process. Despite its potential, the FDA‘s guidance on automated systems mentions AI only briefly, highlighting the need for comprehensive regulation and addressing technical challenges like training, domain knowledge, and data quality. Implementing AI systems requires specialized expertise, precise data labelling, and cloud computing for model training. At this online conference, we will be focussing on GMP regulation and technical aspects. Questions such as
Does an automatic AI solution eliminate the need for manual visual inspection?
When does the use of Artificial Intelligence make sense?
What expectations can be placed on the achievable false
reject rates of AI-supported inspection systems?
Are there applications or technical limitations that even AI-supported systems cannot solve?
How does a project to switch to AI-based visual inspection work?
What GMP authority requirements are there for such systems?
Hintergrund
(AI) Artificial Intelligence in a GxP Environment
The pharmaceutical industry is increasingly interested in AI for the visual inspection of parenterals to optimize and enhance process efficacy. However, the lack of specific regulatory requirements for AI validation poses challenges from a Good Manufacturing Practice (GMP) perspective, such as data representativeness, model design, and data integrity throughout the product lifecycle. In visual inspection, AI aims to improve efficiency by reducing the false acceptance rate (FAR) of defect units and the false reject rate (FRR) of good units, which together determine the misclassification rate and the inspection process‘s effectiveness. A high FAR is associated with a possible quality risk, while the FRR is a measure of the economic damage of the selected control process. Despite its potential, the FDA‘s guidance on automated systems mentions AI only briefly, highlighting the need for comprehensive regulation and addressing technical challenges like training, domain knowledge, and data quality. Implementing AI systems requires specialized expertise, precise data labelling, and cloud computing for model training. At this online conference, we will be focussing on GMP regulation and technical aspects. Questions such as
Does an automatic AI solution eliminate the need for manual visual inspection?
When does the use of Artificial Intelligence make sense?
What expectations can be placed on the achievable false
reject rates of AI-supported inspection systems?
Are there applications or technical limitations that even AI-supported systems cannot solve?
How does a project to switch to AI-based visual inspection work?
What GMP authority requirements are there for such systems?
will be discussed and possible solutions presented.
(AI) Artificial Intelligence in Visual Inspection
At the latest, Artificial Intelligence (AI) has arrived in the general public since ChatGPT and Bard. Opinions range between absolute euphoria and the invocation of the downfall of humanity. The foundations of AI were laid many years ago and can now be widely implemented due to massively available computing power. The topic has also found its way into the pharmaceutical landscape. First applications have come into operation. The interesting questions here are whether and how this technology is compatible with pharmaceutical regulations, specifications and authorities’ expectations.
Zielgruppe
(AI) Artificial Intelligence in a GxP Environment
The Live Online Training is aimed at managers and QA members as well as engineers from the pharmaceutical industry, suppliers and service companies who qualify and operate AI applications in a GxP environment.
(AI) Artificial Intelligence in Visual Inspection
The target group for this event are specialists and managers in the pharmaceutical industry from the fields of engineering, production and quality assurance who are involved in the organisation or operation of visual inspection. This conference is also aimed at suppliers involved in the development and automation of inspection systems.
Technical Requirements
We use Webex for our live online training courses and webinars. At https://www.gmp-compliance.org/training/online-training-technical-information you will find all the information you need to participate in our events and you can check if your system meets the necessary requirements to participate. If the installation of browser extensions is not possible due to your rights in the IT system, please contact your IT department. Webex is a standard nowadays and the necessary Installation is fast and easy.
Programme (AI) Artificial Intelligence in a GxP Environment - 29-30 October 2024
Introduction to Artificial Intelligence (AI)
History of AI
Types of AI
Real life examples
Introduction to Machine Learning (ML)
Technological basics
Different learning / training methods
Example use cases
AI in Image Processing
Introduction to deep learning models for imaging
Deep learning for diagnosis and prognosis
Pre-training of deep learning models
Explainable Artificial Intelligence
AI/ML in Pharma, Biotech, and Med Devices
Challenges for the Life science industry
The GAMP-perspective on AI/ML
Use cases / Known scenarios
Regulatory Requirements / Concerns / Assessment
Pharmaceutical laws
EU-GMP Guide Annex 11
Inspection strategy
What do inspectors expect from the regulated user?
Inspection Readiness
Overview of regulatory guidance and evolving inspection practices
Overview of supporting processes: data management, risk management, change management
Have documentation ready – provide reasoning and justifications
How to setup mock inspections successfully
Data and Models
Overview of model and data types
Data split: training, validation, testing
Data quality, representativeness and typical data challenges
Use of synthetic data
Introduction to and Application of Generative AI in Regulated Pharma
Introduction to Large Language Models (LLM) and example use cases
Specialization and tailoring of LLMs in computerized Systems
Typical risks when using LLMs
Performance evaluation and validation strategies for LLMs
Generative AI - Legal Requirements and practical Implementation
AI and law: introduction and overview
Outlook and update on the EU AI Act
Copyright and trade Secrets
Data protection requirements and processing of personal data
Practical implementation and best practicess
Validation Approaches
Maturity: Increasing autonomy and transferring Control
Governance: Developing and operating AI solutions in GxP-regulated areas
The Use of Artificial Intelligence in Pharmaceutical Manufacturing, Developments, Implementation, and Examples
Risks and Opportunities
Preparing the Quality Management System for AI
Where to implement and what to avoid
Pactical examples and attention Points
Validation requirements
Future Developments
Risk Management for AI/ML
Basics of a ML Risk and Control Framework
Applying QRM to development and operation of AI applications
Using hazard clusters to guide the risk process
Efficiency Increase in Pharma Production Lines through GMP-compliant AI Tools – Case Study Review
Lessons learned from primary and secondary packaging lines and Auto-Injectors production
When continuously learning and situationally acting tools can help and when not
Introduction of Use cases for live learning optimization tools in GMP-environment
Short Intro: AI-based behavior learning on high frequency machine data of whole production lines
Obstacles during validation
Learnings from 24/7-operations Integration
Review of realistic and unrealistic benefits
Trustworthy AI: Innovative Approaches for Transparency in Validation
Black box or partner: How can transparency of AI be increased?
Interpretability of AI-based decisions
Foundations of Explainable AI
Approaches for the validation of AI systems in GxP environment
Programme (AI) Artificial Intelligence in Visual Inspection - 31 October 2024
Reality & Opportunities of AI in the Industrial Environment
What is Artificial Intelligence?
Is GenAI a Game Changer?
Opportunities and risks
Industrial Use cases
Artificial Intelligence (AI) in Visual Inspection from a GMP Inspector‘s Perspective
Legal basis
GAMP® and AI (ML)
Validation
Operation and raw data
Application, Project Planning and Qualification of AI in fully automated Visual Inspection
Development of robust, reliable and production-ready models in 4 phases
Phase 1: Problem identification & description
Phase 2a: Specification of inspection concept
Phase 2b: Definition of the sample sets (artificial and production samples), creation of the datasets, clarification of the labelling strategy
Phase 3: Model design, training and verification - a risk-based approach
Phase 4: Qualification & validation
Processes & technologies
Technologies for efficient image data acquisition, variable model technologies, transfer learning / pre-trained models, labelling application
Documentation of model development: traceability, risk minimisation and build-up of confidence
Usage of AI in the Inspection of hard-to-inspect Container-Systems
Manual, semi-automated and fully-automated approaches
Use of Artificial Intelligence
Single chamber and multi-chamber bags
Inspection of Blow-Fill-Seal containers
Inspection of Form-Fill-Seal containers
General approach
Training and Machine Learning
Testing and Validation
Limitations
Dieses Seminar/Webinar kann nicht gebucht werden. Alternative Termine für dieses Seminar/Webinar und ähnliche Veranstaltungen finden Sie in der Übersicht nach Thema..
Für viele Seminare und Webinare gibt es auch Aufzeichnungen, die Sie jederzeit bestellen und anschauen können. Diese Aufzeichnungen finden Sie in einer themensortierten Liste.
Oder senden Sie uns Ihre Anfrage einfach über das folgende Kontaktformular.
Teilnehmerstimmen - das sagen andere über unsere Seminare:
"Die Umsetzung mit Memberspot ist wirklich ausgezeichnet gelungen. Es unterstützt die Wissensvermittlung und gewährleistet auch die richtige Durchführung des Kurses.” Christian Wagener, WAGENER & CO. GmbH GMP Basis-Einstiegsschulung (B 1) - Aufzeichnung Online Seminar, April 2024
„Austausch zwischen Teilnehmern & Vortragenden sorgt für Anstöße & Optimierungsmöglichkeiten im eigenen Unternehmen! Praxisnahe Beispiele veranschaulichen und vertiefen die Theorie sehr gut“ Marina Maier, CHEPLAPHARM Arzneimittel GmbH
Abweichungen und CAPA (QS 12) November 2024
„Danke für das tolle und interessante Seminar! Ich nehme mir fachlich total viel mit und habe viele tolle Menschen kennengelernt.“ Melanie Schifferer, DAIICHI SANKYO EUROPE GmbH Batch Record Review (QS 23) September 2024
„Guter, breit gefächerter Überblick mit interessanten Verknüpfungen zur Praxis, welche die Theorie super veranschaulicht.” Marina Kicoranovic, Labor Hartmann GmbH GMP/Basis-Einstiegsschulung (B 14), September 2023
„Die Referenten waren sehr gut! Sie haben sehr klar gesprochen, nur sehr wenige englische Begriffe verwendet (super) und waren sehr praxisbezogen.” Astrid Gießler, Regierungspräsidium Karlsruhe Live Online Seminar - Basiskurs Computervalidierung & Datenintegrität im GxP Umfeld (B 3), Juni 2023
„Sehr guter Bezug zur Schulung für einen GMP-Anfänger. Habe mich sehr gut abgeholt gefühlt.” Dr. Harald Werner, Infraserv GmbH & Co. Höchst KG GMP-Basisschulung (B 1), Juni 2023
„Interessante Themen, gut vorgetragen, die eigenen Erfahrungen der Vortragenden helfen, dies noch besser nachzuvollziehen.“ „Gute Gestaltung der Workshops, das Zusammenarbeiten in Gruppen und der Austausch mit anderen hilft sehr.“ Manuela Seibert, Merck, GMP-Leadauditor/in (FA 2), April 2024